KITLG and cancer: Since NUB1 controls the cell cycle progression via the upregulation of p27Kip1 [18], overexpression of NUB1 and NUB1L may prevent the activities of SCF family proteins via suppressing the ligase activity of SCF complexes to treat malignant phenotypes in cancer cells [20].